Funding research! A funders or donor’s intent relates to the purposeful state of mind behind the act of giving. The desire and hope that their the gift will contribute to achieve a greater community good is often philanthropist’s underlying intent. The same can be said about the community’s willingness to give or support a cause. […]VIEW POST
Measurements and rewards influence behaviour. They not only influence what is performed, but also what is not. Key performance indicators are often used to measure the performance of employees; they prioritise activities and drive behaviour. The measures, rewards and potential of future grant successes that funders of research and their employers put into the research […]VIEW POST
Australia’s innovation efficiency is a wicked problem needing a solution. The ability for Australia to capitalise on its research efforts has consistently ranked well below expectations. One of the key opportunities for philanthropy is to innovate and test solutions that can be scaled to assist in solving wicked problems such as this and contribute towards […]VIEW POST
Bridging the Valley-of-Death to Create a Path to Successes, a Case for Publically Funded Drug Discovery.
Written by Associate Professor Bernard Flynn The Opportunity: The pharmaceutical sector is one of the most profitable industries in the world. The top 10 selling drugs all have annual sales in excess of US$6 bil pa. In the last 20 yrs the sector has been transformed, with many larger Pharma companies preferring to build […]VIEW POST
I started writing this post to provoke a conversation and scratch the surface on an important issue. There are many differing points of view and most are valid, and less valid at the same time depending on the lens you are looking through. Measuring impact from research requires a more sophisticated or complex conversation than […]VIEW POST
Back in the nineties, when the Biotechnology sector was emerging, Signals Magazine published a series of articles “How the Elephants Dance”. This series explored how the biotechnology sector and big pharmaceutical companies interacted together and with each other to bring new medicines, vaccine, diagnostics and devices to market where those in need could access the […]VIEW POST
Without caution evaluating grant applications and measuring impact can sometimes be like using an elastic tape measure.
The Age recently published an article ‘The dodgy academic journals publishing anti-vaxxers and other ‘crappy science’. The article describes a booming black market duping academics into submitting their research for a fee of up to $3000 a paper and notes the increasing number of reputable journals charging researchers to submit or cite their publications. We […]VIEW POST
Join a conversation with philanthropists, researchers, industry and government. Delivering impact from medical research.
In order to harness the benefits from medical research it is important to bring all key stakeholders together, including philanthropy, industry, government and academia. NFMRI’s conference uniquely provides this opportunity, creating an interactive forum to discuss opportunities, issues and ideas. We encourage delegates to submit questions in advance and contribute to the conversation. The […]VIEW POST
The ‘halo effect’ can be both a positive and negative for funders of research. How does it affect you?
A challenge for funders of research is that it often requires more than research to achieve their ultimate goals. Restricting funding to research is often set out in the terms of; a bequest, a donation, a grant, the constitution and may be a requirement for the funder to maintain charitable status. The outcome funders wish […]VIEW POST
Could this be a reality? We all know that not all good ideas gain traction and become reality. This is true for inventors, for business, for things around the home and for medical research. Discoveries and good ideas that are never disclosed and disappear without a trace may later be rediscovered and lead to future […]VIEW POST